Recently, it was proved that CtBP2 reduced chemosensitivity of non-small cell lung cancer cells to cis-diamminedichloroplatinum (CDDP) via promoting the Wnt/β-catenin pathway (20). Here, CTBP2 is linked to non-small cell lung carcinoma.